Rhythm Pharmaceuticals
RYTM
RYTM
90 hedge funds and large institutions have $191M invested in Rhythm Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
50% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 36
66% less capital invested
Capital invested by funds: $563M → $191M (-$372M)
Holders
90
Holding in Top 10
1
Calls
$1.67M
Puts
$120K
Top Buyers
| 1 | +$6.22M | |
| 2 | +$1.57M | |
| 3 | +$1.5M | |
| 4 |
E
Ergoteles
New York
|
+$883K |
| 5 |
Morgan Stanley
New York
|
+$727K |
Top Sellers
| 1 | -$8.74M | |
| 2 | -$3.61M | |
| 3 | -$2.78M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.62M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.32M |